Análisis Argos
HCM
HCMSin veredicto2 señales de riesgo
HUTCHMED (China) Limited · Healthcare
US$ 11.65
precio al 2026-07-07
Valor justo Argos*
Sin estimar
vs. su valor justo
Sin estimar
Score Argos
19/100
Sin veredicto
LA RESPUESTA
No tenemos un veredicto de valuación confiable acá: su flujo de caja no permite una estimación sólida. Mirá su calidad y su salud para formarte una idea — preferimos eso a inventarte un número.
Recompensas
Las ganancias crecieron 1114% el último año.
Riesgos
!Balance frágil: la deuda pesa sobre el negocio.
!Beneish M-Score sugiere manipulación (-1.18)
!FCF negativo con deuda creciente
VALOR1/6FUTURO4/6PASADO0/6SALUD2/6DIVIDENDO1/6
El Iris de calidad
VALOR1/6FUTURO4/6PASADO0/6SALUD2/6DIVIDENDO1/6
ValorCotiza por encima de su valor justo
FuturoIngresos creciendo con fuerza
PasadoHistorial débil
SaludBalance razonable
DividendoEl dividendo aún duerme
Score Argos19de 100Sin veredicto
Ingresos13%
US$ 0.6 B
Margen operativo45%
-10%
Flujo de caja libre300%
US$ -0.1 B
Deuda neta
US$ 0 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 2.0B
P/E4.4x
EV/EBITDA
FCF yield-3.9%
ROIC-3.8%
Margen operativo-10%
Crecim. ingresos-12.7%/año
Piotroski F4/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

globenewswire.com · 2 jul
HUTCHMED Announces NMPA Approval for ORPATHYS® for the treatment of Gastric Cancer Patients with MET Amplification
First selective MET inhibitor approved for patients with MET-amplified advanced gastric cancer or gastroesophageal junction adenocarcinoma in China First selective MET inhibitor approved for patients with MET-amplified advanced gastric cancer or gastroesophageal junction adenocarcinoma in China
globenewswire.com · 30 jun
HUTCHMED to Announce 2026 Half-Year Financial Results
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2026 on Thursday, July 30, 2026 at 7:00 am Eastern Daylight Time (EDT) / 12:00 noon British Summer Time (BST) / 7:00 pm Hong Kong Time (HKT).
zacks.com · 26 jun
Buy These 3 HCM Software Solution Stocks to Tap Short-Term Potential
AI-driven hiring and HR automation are reshaping HCM software, with three companies, namely, PAYC, PCTY and FA standing out for short-term upside.
businesswire.com · 23 jun
Syndio Acquires Embrace.ai
SEATTLE--(BUSINESS WIRE)--Syndio, the Decision Intelligence for Pay company, today announced the acquisition of Embrace.ai, an agentic AI company built to deploy AI-driven automation across business workflows. The full Embrace.ai team, led by founders and enterprise software veterans Derek Butts and Seth Halpern, will join Syndio's product and go-to-market organization. The acquisition bolsters the Syndio team with deep experience across enterprise human capital management (HCM), large-scale so.
globenewswire.com · 16 jun
isolved Introduces Autonomous AI Agents Built to Own HR Outcomes — Brings Unified HCM Platform to Anthropic's Claude Connectors Directory
LAS VEGAS, June 16, 2026 (GLOBE NEWSWIRE) -- Connect For Partners -- isolved ® today unveiled the first autonomous AI agents built to own HR, payroll and benefits outcomes, and launched general availability of the isolved Connector for Claude. The announcement arrives as AI agents proliferate inside the American workforce without systems of record, governance, or accountability — a workforce problem disguised as a software problem.
prnewswire.com · 16 jun
Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)
– No relationship observed between EDG-7500 exposure and LVEF; no LVEF reductions below 50% – – Consistent and clinically meaningful improvements observed in echocardiogram parameters, biomarkers, symptoms and functional status across obstructive and nonobstructive HCM  – – EDG-7500 administration continued to be generally well tolerated – – Company to host webcast today at 8:30 a.m. Eastern Time – BOULDER, Colo.
globenewswire.com · 15 jun
isolved Honors Top-Performing Partners at Annual Connect for Partners Event
LAS VEGAS, June 15, 2026 (GLOBE NEWSWIRE) -- Connect for Partners – isolved®, a provider of human capital management (HCM) solutions that help organizations recruit, retain and elevate their workforce, proudly recognized top-performing partners during its annual isolved Connect for Partners. Now in its ninth year, Connect for Partners has grown into the premier gathering for the isolved partner community bringing together hundreds of HR and benefits providers for immersive product deep-dives, peer connection and forward-looking strategy sessions designed to sharpen competitive edge and accelerate client outcomes.
globenewswire.com · 15 jun
isolved Introduces New Strategic Marketplace Partners at Connect 2026, Extending People Cloud™ Capabilities for Employers and Employees
LAS VEGAS, June 15, 2026 (GLOBE NEWSWIRE) -- Connect For Partners – isolved, a provider of human capital management (HCM) solutions that help organizations recruit, retain and elevate their workforce, today announced new additions to its Strategic Marketplace — a curated ecosystem of best-in-class technology partners, each selected for the specific, meaningful value they bring to isolved clients and their employees. These additions — Corestream, Electric, OrgChart, PosterElite and Remote — extend the power of isolved People Cloud™ with trusted partner solutions built to streamline, scale and support every stage of the employee experience.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.